Antiemetics are therapeutic agents that are effective against nausea and vomiting. Nausea and vomiting are the symptoms of several medical conditions such as motion sickness, dizziness, pregnancy, emotional stress and food poisoning. These drugs are often used to treat the side effects of other medications including opioid analgesics, Chemotherapy and general anesthetics. Global antiemetics market is expected to grow with healthy CAGR during the forecast period due to increase in number of patients suffering from cancer and increased number of surgeries. In-depth discussion of global antiemetics market includes past and current trends with future forecast up to 2020. Profound assessment of threats and opportunities for new and existing companies running the business in this market would be beneficial to strategist in their respective decision making process. The report is informative towards geographical segmentation and identifies profitable areas.
Over the few years, antiemetics have witnessed sudden increase in sale due to increasing number of cancer patients. Nausea and vomiting are the common symptoms of chemotherapy and high risk chemotherapeutic agents include Carmustine and Cisplatin. Additional market drivers include extensive research activities to innovate universal antiemetic drug therapy, use of novel drug delivery to improve patient compliance and identification of new drug targets. However, the antiemetic drugs, which are in clinical phase requires improvement in clinical trial design for their commercialization. Moreover, lack of suitable animal model that will mimic the human responses to antiemetic therapy also restraints the market growth. Novel drug therapies and new drug targets are the opportunities for manufacturers that would help them to increase their market share.
Global Antiemetics Market by Type
The antiemetics market is segmented by type of drugs into different categories such as 5-HT3 receptor antagonists, Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids and Others. 5-HT3 receptor antagonists, Dopamine antagonists and Cannabinoids are popular categories of antiemetics. Dronabinol is the largest selling drug from Cannabinoids, whereas Domperidone dominates the dopamine antagonists. Ondansetron, Dolasetron and Palonosetron are the top selling drugs from 5-HT3 receptor antagonists.
Global Antiemetics Market by Application
Antiemetics are used to treat the emesis arising from several medical conditions and include Chemotherapy, Motion sickness, Gastroenteritis, general anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress and Others. Chemotherapy leads the application segment as number of patients suffering from cancer is increasing day by day.
Global Antiemetics Market by Geography
Geographically, global antiemetics market is segmented into North America, Europe, Asia-pacific and LAMEA. North America and Europe leads the global antiemetics market due to high incidence of cancer. Asia-Pacific is the fastest growing market due to increasing number of cancer population, high incidences of gastroenteritis and other diseases that lead to nausea and vomiting.
The leading companies in global antiemetics market include GlaxoSmithCline, Merck, Sanofi-Aventis, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Astellas Pharma, Johnson & Johnson, Baxter International and others. Antiemetics market has witnessed a strong competition due to large number of companies are trying to focus their R&D efforts to manufacture universal antiemetic therapy, which would offer improved patient compliance. Competitors are also focusing on novel drug deliveries that would show better outcomes as compared to conventional therapies.
High Level Analysis
- Thorough attention is given to leading company portfolios, pipeline research, new launches and competitive landscape of top players
- Explicit information on current clinical trials and R&D activities would be beneficial to understand the future market trends
- Insightful analysis of different segments helps to recognize and capitalize future opportunities within global antiemetics market
The global antiemetic drugs market is segmented into three major categories such as type, application and geography.
MARKET BY TYPE
- 5-HT3 receptor antagonists
- Dopamine antagonists
- NK1 receptor antagonist
- Antihistamines (H1 histamine receptor antagonists)
MARKET BY APPLICATION
- Motion sickness
- General anesthetics
- Opioid analgesics
- Food poisoning
- Emotional stress
MARKET BY GEOGRAPHY
- North America
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.